Coastal Investment Advisors, Inc. Amgen Inc Transaction History

Coastal Investment Advisors, Inc.

$211 Million
Q3 2024

A detailed history of Coastal Investment Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Coastal Investment Advisors, Inc. holds 2,056 shares of AMGN stock, worth $539,144. This represents 0.31% of its overall portfolio holdings.

Number of Shares

2,056

Previous 1,210 69.92%

Holding current value

$539,144

Previous $378,000 75.13%

% of portfolio

0.31%

Previous 0.07%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$309.38 - $337.38 $261,735 - $285,423	846 Added 69.92%	2,056 $662,000
Q2 2024 Jul 15, 2024	BUY	$262.75 - $319.31 $29,953 - $36,401	114 Added 10.4%	1,210 $378,000
Q1 2024 Apr 19, 2024	SELL	$268.87 - $324.56 $58,344 - $70,429	-217 Reduced 16.53%	1,096 $311,000
Q4 2023 Jan 19, 2024	SELL	$255.7 - $288.46 $42,190 - $47,595	-165 Reduced 11.16%	1,313 $378,000
Q3 2023 Oct 20, 2023	SELL	$218.65 - $271.46 $15,305 - $19,002	-70 Reduced 4.52%	1,478 $397,000
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $18,212 - $21,536	-85 Reduced 5.21%	1,548 $343,000
Q1 2023 May 05, 2023	SELL	$225.79 - $275.2 $106,572 - $129,894	-472 Reduced 22.42%	1,633 $394,000
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $86,115 - $109,419	-376 Reduced 15.16%	2,105 $552,000
Q3 2022 Oct 27, 2022	BUY	$224.46 - $253.15 $11,671 - $13,163	52 Added 2.14%	2,481 $559,000
Q2 2022 Aug 09, 2022	SELL	$230.71 - $256.74 $5,767 - $6,418	-25 Reduced 1.02%	2,429 $596,000
Q1 2022 Apr 13, 2022	BUY	$219.27 - $242.57 $86,173 - $95,330	393 Added 19.07%	2,454 $593,000
Q4 2021 Jan 18, 2022	BUY	$198.88 - $227.6 $62,846 - $71,921	316 Added 18.11%	2,061 $464,000
Q3 2021 Oct 18, 2021	BUY	$212.27 - $248.7 $3,396 - $3,979	16 Added 0.93%	1,745 $371,000
Q2 2021 Jul 15, 2021	SELL	$233.58 - $259.14 $99,505 - $110,393	-426 Reduced 19.77%	1,729 $421,000
Q1 2021 Apr 12, 2021	SELL	$221.91 - $258.6 $51,926 - $60,512	-234 Reduced 9.79%	2,155 $536,000
Q4 2020 Jan 13, 2021	BUY	$216.38 - $257.67 $9,520 - $11,337	44 Added 1.88%	2,389 $549,000
Q3 2020 Oct 23, 2020	BUY	$234.65 - $260.95 $145,952 - $162,310	622 Added 36.1%	2,345 $596,000
Q2 2020 Jul 16, 2020	SELL	$197.81 - $242.74 $2,967 - $3,641	-15 Reduced 0.86%	1,723 $406,000
Q1 2020 Apr 23, 2020	SELL	$182.24 - $241.7 $313,270 - $415,482	-1,719 Reduced 49.73%	1,738 $352,000
Q4 2019 Feb 05, 2020	SELL	$189.21 - $243.2 $40,112 - $51,558	-212 Reduced 5.78%	3,457 $808,000
Q3 2019 Oct 18, 2019	SELL	$174.11 - $208.62 $56,237 - $67,384	-323 Reduced 8.09%	3,669 $709,000
Q2 2019 Aug 01, 2019	BUY	$166.7 - $195.41 $225,711 - $264,585	1,354 Added 51.33%	3,992 $736,000
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $477,135 - $537,835	2,638 New	2,638 $501,000

Others Institutions Holding AMGN

# of Institutions

3,119

Shares Held

407M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.

Account

Coastal Investment Advisors, Inc. Amgen Inc Transaction History